Description of Pra Health Sciences Inc's Business Segments
PRA Health Sciences Inc. is recognized as one of the leading Contract Research Organizations (CROs) globally, specializing in a wide array of segments, products, and services that cater to the demands of pharmaceutical and biotechnology companies throughout the drug development lifecycle.
Segments
1. Clinical Development: - Clinical Trial Management: PRA oversees the design, implementation, and execution of clinical trials, ensuring compliance with regulatory requirements and therapeutic protocols. - Site Management: This entails the selection and management of clinical trial sites, along with staff training and logistical support to ensure optimal performance. - Monitoring: PRA employs clinical research associates (CRAs) who monitor clinical sites for compliance with Good Clinical Practice (GCP) and overall trial integrity. - Patient Recruitment: Specialized teams focus on targeted recruitment strategies to ensure diverse and adequate patient populations for trials. - Safety Monitoring: Ongoing assessment of patient safety through adverse event tracking and reporting, utilizing robust pharmacovigilance practices.
2. Strategic Solutions: - Drug Development Consulting: Providing comprehensive advice across all phases of drug development to align with regulatory requirements and market needs. - Regulatory Consulting: Assistance with regulatory submissions, including IND applications and responses to regulatory inquiries to facilitate smooth interactions with regulatory bodies. - Pharmacovigilance: Monitoring the safety of pharmaceutical products throughout their lifecycle to ensure ongoing compliance with safety regulations and risk management plans. - Medical Writing: Creation of essential documentation including clinical study reports, regulatory submissions, and scientific publications, ensuring clarity and adherence to industry standards.
3. Early Development: - Non-Clinical Safety Assessment: Conducting toxicology studies to evaluate the safety profile of drug candidates before they enter clinical trials. - Clinical Pharmacology: Design and execution of clinical pharmacology studies to assess drug absorption, distribution, metabolism, elimination, and effects in humans. - Bioanalytical Services: Offering analytical services for assessing drug levels in biological samples, providing crucial pharmacokinetic data. - Bioequivalence Studies: Conducting studies to establish the equivalence of generic drugs to their branded counterparts.
Products
1. PRAes EDC (Electronic Data Capture) Systems: - A state-of-the-art EDC platform that replaces traditional paper-based systems with an efficient, user-friendly electronic solution. This platform enhances data collection accuracy, facilitates real-time monitoring, and streamlines data management processes.
2. PRAes Technologies: - A comprehensive suite of integrated technology solutions designed to enhance clinical trial efficiency: - Clinical Trial Management Systems (CTMS): Tools that manage trial processes, resource allocation, and data storage effectively. - Interactive Response Technology (IRT): Streamlining randomization and drug supply management to ensure timely and accurate distribution of study drugs. - Electronic Patient-Reported Outcomes (ePRO): Digital solutions empowering patients to report on their health status directly, improving data quality and patient engagement.
Services
1. Clinical Research: - Providing end-to-end clinical research services, from the initiation phase through to the closure of clinical trials. This encompasses protocol development, study execution, site monitoring, and final reporting.
2. Data and Analytics: - Delivering comprehensive data analysis services tailored to the unique needs of clients, utilizing advanced statistical methodologies to extract insights from complex datasets. This includes data visualization and management to support decision-making processes.
3. Post-Approval Services: - A robust offering of services designed to support pharmaceuticals and biotechnology companies post-product approval, including: - Pharmacovigilance: Ongoing monitoring and reporting of drug safety data. - Medical Affairs: Strategic communications and scientific engagement with healthcare professionals to ensure successful product incorporation into treatment paradigms. - Regulatory Services: Continuous compliance support as products transition from development into the marketplace.
4. Real World Solutions: - PRA leverages real-world evidence to provide actionable insights, which include: - Observational Studies: Research analyzing the use and effectiveness of treatments in real-world settings. - Patient Registries: Establishing registries to track patient outcomes and treatment patterns in specific populations. - Health Economics Research: Analyzing economic aspects of healthcare interventions to support market access and value propositions.
Conclusion
PRA Health Sciences Inc. stands out as a comprehensive, full-service CRO, offering an extensive range of segments, products, and services. They aim to partner closely with pharmaceutical and biotechnology firms, leveraging their deep expertise and innovative technologies to accelerate the development and success of new therapeutic interventions in the marketplace.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
